Answer
The minimum age for Qarziba (dinutuximab beta) treatment of high-risk neuroblastoma is 12 months.
Sources for this answer
- Qarziba (Dinutuximab beta)Recordati UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 13Document updated
Sources checked